Compound W for Kids One Step Strips

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, “cauliflower-like” surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and disruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 3 years and older, the affected area should be washed thoroughly. It is recommended to soak the wart in warm water for 5 minutes to facilitate treatment. After soaking, the area must be dried completely. The medicated pad should be removed from the backing paper by pulling from the center of the pad, and then it should be applied directly to the wart. This procedure may be repeated every 48 hours as needed, continuing until the wart is removed, for a maximum duration of 12 weeks.

For children under 3 years of age, it is advised to consult a doctor before proceeding with treatment.

Contraindications

Use is contraindicated in the following situations:

• Application on irritated skin or any area that is infected or reddened is prohibited due to the potential for exacerbating the condition.

• The product should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes, as these conditions may lead to adverse reactions.

• Patients with diabetes or poor blood circulation should not use this product, as these conditions may increase the risk of complications.

Warnings and Precautions

For external use only. This product is contraindicated for application on irritated skin or any area that is infected or reddened. It should not be used on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. Additionally, individuals with diabetes or poor blood circulation should refrain from using this product.

Healthcare professionals should advise patients to discontinue use and seek medical advice if discomfort persists. In the event of accidental ingestion, immediate medical assistance is required. Patients should be instructed to contact a Poison Control Center at 1-800-222-1222 without delay.

Side Effects

Patients should be aware that the product is for external use only. It is contraindicated for use on irritated skin or any area that is infected or reddened. Additionally, the product should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes. Patients with diabetes or poor blood circulation should also refrain from using this product.

In the event that discomfort persists after application, patients are advised to stop use and consult a healthcare professional. It is crucial to keep this product out of reach of children. If swallowed, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Compound W for Kids One Step Strips (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 3 years and older may use the medicated pad for wart treatment. The affected area should be washed, and the wart may be soaked in warm water for 5 minutes before drying thoroughly. The medicated pad should be removed from the backing paper by pulling from the center and applied to the wart. This procedure may be repeated every 48 hours as needed until the wart is removed, with a maximum treatment duration of 12 weeks.

For children under 3 years of age, consultation with a doctor is advised prior to use.

Geriatric Use

There is no specific information regarding the use of Compound W for Kids One Step Strips in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution when considering the use of this product in patients aged 65 and older, as the absence of data necessitates careful monitoring and individualized assessment of treatment risks and benefits in this population.

Pregnancy

Pregnant patients should be advised against using this product on irritated skin or on any area that is infected or reddened. Additionally, it is contraindicated for use on moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes.

Women of childbearing potential with diabetes or poor blood circulation should also avoid using this product due to potential risks. Furthermore, it is recommended that children under 3 years of age consult a healthcare professional prior to use.

The safety of this product during pregnancy has not been established, and caution is advised.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals are advised to seek medical help or contact a Poison Control Center at 1-800-222-1222 without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. It is important for healthcare providers to assess the patient's condition and initiate appropriate management procedures based on the severity of symptoms and the specific substance involved.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Skin discoloration has been reported in postmarketing experience, occurring during or after the use of the product. These events were documented through voluntary reports and surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is crucial to emphasize the importance of safety in the home environment, particularly for households with young children.

In the event that the medication is swallowed, healthcare providers should instruct patients to seek medical help immediately or contact a Poison Control Center at 1-800-222-1222. This prompt action is essential to ensure the safety and well-being of the patient.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, ensuring that the storage environment does not exceed excessive heat of 37°C (99°F). Proper handling should be observed to maintain the integrity of the product during storage.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Compound W for Kids One Step Strips, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)